Ultragenyx Pharmaceutical Inc (RARE)
46.61
+0.21
(+0.45%)
USD |
NASDAQ |
Nov 21, 15:22
Ultragenyx Pharmaceutical Market Cap: 4.304B for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 4.285B |
| November 19, 2024 | 4.167B |
| November 18, 2024 | 4.043B |
| November 15, 2024 | 4.132B |
| November 14, 2024 | 4.399B |
| November 13, 2024 | 4.498B |
| November 12, 2024 | 4.418B |
| November 11, 2024 | 4.685B |
| November 08, 2024 | 4.650B |
| November 07, 2024 | 4.657B |
| November 06, 2024 | 4.665B |
| November 05, 2024 | 4.819B |
| November 04, 2024 | 4.715B |
| November 01, 2024 | 4.709B |
| October 31, 2024 | 4.709B |
| October 30, 2024 | 4.785B |
| October 29, 2024 | 4.874B |
| October 28, 2024 | 4.899B |
| October 25, 2024 | 4.968B |
| October 24, 2024 | 5.060B |
| October 23, 2024 | 5.048B |
| October 22, 2024 | 5.057B |
| October 21, 2024 | 5.027B |
| October 18, 2024 | 5.193B |
| October 17, 2024 | 5.240B |
| Date | Value |
|---|---|
| October 16, 2024 | 5.326B |
| October 15, 2024 | 5.272B |
| October 14, 2024 | 5.187B |
| October 11, 2024 | 5.086B |
| October 10, 2024 | 4.972B |
| October 09, 2024 | 4.927B |
| October 08, 2024 | 4.920B |
| October 07, 2024 | 4.840B |
| October 04, 2024 | 4.965B |
| October 03, 2024 | 4.953B |
| October 02, 2024 | 5.128B |
| October 01, 2024 | 5.216B |
| September 30, 2024 | 5.128B |
| September 27, 2024 | 5.017B |
| September 26, 2024 | 5.089B |
| September 25, 2024 | 5.231B |
| September 24, 2024 | 5.298B |
| September 23, 2024 | 5.305B |
| September 20, 2024 | 5.415B |
| September 19, 2024 | 5.417B |
| September 18, 2024 | 5.318B |
| September 17, 2024 | 5.391B |
| September 16, 2024 | 5.471B |
| September 13, 2024 | 5.414B |
| September 12, 2024 | 5.330B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
1.957B
Minimum
Mar 16 2020
11.74B
Maximum
Dec 23 2020
4.559B
Average
4.024B
Median
May 06 2022
Market Cap Benchmarks
| Alnylam Pharmaceuticals Inc | 31.79B |
| NovaBay Pharmaceuticals Inc | 3.327M |
| Palatin Technologies Inc | 17.88M |
| iBio Inc | 21.96M |
| Theriva Biologics Inc | 3.450M |
Market Cap Related Metrics
| PS Ratio | 7.748 |
| Price to Book Value | 12.41 |
| Price | 46.61 |
| Earnings Yield | -13.88% |